Clinuvel Pharmaceuticals Logo

Clinuvel Pharmaceuticals

🇦🇺
CUV
AU000000CUV3

Clinuvel Pharmaceuticals is a global biopharmaceutical company headquartered in Australia. The firm focuses on the development of innovative drugs for rare skin disorders. Through the application of specialized therapies, Clinuvel improves the quality of life for patients across the globe.

Next Quarterly Earnings

Wednesday, February 24, 2027
Expected

Stock Price

Frequently asked questions

When did Clinuvel Pharmaceuticals last report quarterly earnings?

Clinuvel Pharmaceuticals last reported quarterly earnings on 8/27/2026 (Q2 2026). Earnings per share (EPS) came in at 0.47 AUD.

How do I add the Clinuvel Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Missed
Estimate:A$0.50
Actual:A$0.47
Difference:-A$0.03
Price reaction (1 day):-12.7 %
Price reaction (7 days):-21.5 %
Q4 2025
Missed
Estimate:A$0.30
Actual:A$0.21
Difference:-A$0.09
Price reaction (1 day):-9.3 %
Price reaction (7 days):-8.2 %

Company Information

Name
Clinuvel Pharmaceuticals
Ticker Symbol
CUV
ISIN
AU000000CUV3
Country
🇦🇺
Australia
Sector